Study of a New Drug Combination in Healthy Adults
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests how a new combination of drugs (BR3006A, BR3006B, and BR3006C) is absorbed and processed by the body when taken together, compared to a single tablet (BR3006). It is for healthy adults to understand the safety and behavior of the medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 19 years old or older.
- You need to be in good general health as confirmed by routine lab tests and an electrocardiogram (ECG).
- You must not have taken part in another clinical trial (including bioequivalence studies) in the last 6 months.
- You must not have had stomach or bowel surgery (other than appendix or hernia repair) or have a stomach/bowel disease that could affect how the study drug is absorbed.
- If you are a woman, you must not be pregnant, think you might be pregnant, or be breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests how the body processes different forms of a drug called BR3006 in healthy volunteers. It compares a single tablet (BR3006) to a combination of three separate components (BR3006A, BR3006B, and BR3006C) given together. This helps researchers understand if the combination works the same as the single tablet.
This trial tests a combination of three diabetes medicines (dapagliflozin, linagliptin, and metformin) in healthy adults to see how safe they are and how the body processes them. Participating could help make sure these medicines are safe for people with diabetes.
This study tests how three common diabetes medicines (dapagliflozin, linagliptin, and metformin) are absorbed when taken with food in healthy adults. It helps doctors understand safe dosing and potential interactions.
This study tests a new medicine (HM11260C) to see if it helps people with type 2 diabetes who are already taking metformin and dapagliflozin but still have high blood sugar. If you qualify, it could give you a new option to better control your diabetes.
This trial tests a combination of three common diabetes medications (metformin, an SGLT2 inhibitor, and a TZD) to see how well they work together and if they are safe. It may help people with type 2 diabetes who need better blood sugar control.
This trial tests a new drug called AD-123 and compares it to taking two other drugs (AD-1231 and AD-1232) together. It is for healthy adults to see how the body handles the drugs and if they are safe.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.